In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
出版年份 2019 全文链接
标题
In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 63, Issue 6, Pages -
出版商
American Society for Microbiology
发表日期
2019-04-04
DOI
10.1128/aac.00470-19
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In vitro activity of the new β-lactamase inhibitors relebactam and vaborbactam in combination with β-lactams against Mycobacterium abscessus complex clinical isolates
- (2019) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Omadacycline for Community-Acquired Bacterial Pneumonia
- (2019) Roman Stets et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
- (2019) William O’Riordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mycobacterium abscessus and antibiotic resistance: Same as it ever was
- (2019) David E Griffith CLINICAL INFECTIOUS DISEASES
- In vitro activities of omadacycline against rapidly growing mycobacteria
- (2019) Carolyn Shoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline
- (2018) Joseph V. Newman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections
- (2018) Joseph S Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus
- (2017) Amit Kaushik et al. Future Microbiology
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease
- (2016) Beatriz E. Ferro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic
- (2016) S. Ken Tanaka et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
- (2015) R Andres Floto et al. THORAX
- Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
- (2014) R. J. Wallace et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011
- (2013) Felix C Ringshausen et al. BMC INFECTIOUS DISEASES
- Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan
- (2013) Chien-Wen Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
- (2010) D. Rebecca Prevots et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing
- (2010) Yi-Ching Huang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
- (2009) K. A. Nash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search